Profound Medical GAAP EPS of $0.27 beats by $0.55, revenue of $6M misses by $1.72M
Source: SeekingAlpha
2026-03-05 16:29:51 ET
More on Profound Medical Corp.
- Profound Medical announces pricing of up to $40 million financing
- Seeking Alpha’s Quant Rating on Profound Medical Corp.
- Historical earnings data for Profound Medical Corp.
- Financial information for Profound Medical Corp.
Read the full article on Seeking Alpha
For further details see:
Profound Medical GAAP EPS of $0.27 beats by $0.55, revenue of $6M misses by $1.72M
Profound Medical Corp.
NASDAQ: PROF
PROF Trading
-4.61% G/L:
$5.59 Last:
187,661 Volume:
$5.65 Open:
PROF Latest News
March 13, 2026 10:30:00 am
CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure(TM) to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
March 09, 2026 08:30:00 am
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
March 05, 2026 04:05:00 pm
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
PROF Stock Data
$191,163,115
29,378,933
5.23%
23
N/A
Medical Equipment & Supplies
Healthcare
CA
Mississauga
